foxo4-dri peptide senolytic FoxO4 DRI - paula-s-choice-peptide-lip-gloss FoxO4 DRI FOXO4-DRI Peptide: A Targeted Approach to Cellular Senescence

fragment-176-191-peptide-fat-loss The quest for interventions that promote healthy aging and combat age-related decline has led to significant interest in senolytic peptides, and among these, FOXO4-DRI has emerged as a molecule of considerable scientific attention.Peptide inhibitors targeting FOXO4-p53 interactions and ... This peptide is designed to selectively target and eliminate senescent cells, a hallmark of aging that contributes to various chronic diseases and tissue dysfunction. Understanding the mechanisms and applications of FOXO4-DRI peptide offers a glimpse into the future of cellular rejuvenation and therapeutic strategiesBackground.FOXO4-DRIis a cell-permeablepeptideantagonist.FOXO4-DRIis an anti-agingpeptidethat induces apoptosis in senescent cells. Chemical Properties ....

FOXO4-DRI: Mechanism of Action

At its core, FOXO4-DRI operates by disrupting the interaction between FOXO4 and p53Cleara Biotech senolytic candidate FOXO4-DRI. p53 is a critical tumor suppressor protein that plays a vital role in cell cycle arrest and apoptosis in response to cellular damage. When cells become senescent, they often accumulate damage and enter a state of irreversible growth arrest, while evading programmed cell death2025年6月6日—相关多肽 · UBX0101：另一种senolytic肽，靶向Bcl-xL 蛋白，与FOXO4-DRI机制互补，联用可增强衰老细胞清除效率¹⁰。 · AP20187 · p53-derivedpeptides.... This evasion is partly facilitated by the interaction between FOXO4 and p53, which can prevent p53 from initiating apoptosis in these damaged cellsMolecular modelling of the FOXO4-TP53 interaction to ....

The FOXO4-DRI peptide acts as a senolytic agent by competitively binding to FOXO4, thereby preventing it from interacting with p53US20200255489A1 - Novel Senolytic Peptides. This disruption frees p53 to execute its apoptotic function, leading to the selective elimination of senescent cells. This targeted approach is crucial, as it aims to remove detrimental senescent cells without harming healthy, functional cells. Research has demonstrated that FOXO4-DRI can induce apoptosis specifically in senescent fibroblasts and chondrocytes, suggesting its potential utility across different tissue types作者：MP Baar·2017·被引用次数：1582—Stepwise addition of theFOXO4-DRI peptideto this complex caused the CSPs of FOXO4 to be reverted back to the unbound state, indicating FOXO4- ....

Therapeutic Potential and Applications

The ability of FOXO4-DRI to selectively clear senescent cells opens up a broad spectrum of potential therapeutic applications.Senolytic Peptide FOXO4-DRISelectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes. Autologous chondrocyte implantation (ACI) is a ... Studies have explored its efficacy in various contexts:

* Fibroblast Senescence: Research has shown that FOXO4-DRI can induce apoptosis in senescent fibroblasts, including those found in keloids.作者：X Han·2022·被引用次数：32—Importantly, the same as othersenolyticagents, it can be used to treat PF even when pathological changes have occurred.FOXO4-DRIis a cell- ... This suggests a potential role in wound healing and the management of fibrotic conditions.

* Cartilage Formation: While FOXO4-DRI has been shown to remove senescent cells in chondrocytes, its utility in promoting cartilage formation from in vitro expanded chondrocytes is an area of ongoing investigation.

* Cancer Cell Elimination: Senolytic peptides like FOXO4-DRI have been investigated for their ability to eliminate senescent human cancer cells in both cell culture and in vivo mouse models.作者：YX Kong·2025·被引用次数：9—We further demonstrate that asenolyticFOXO4-D-retro-inverso-isoformpeptide(FOXO4-DRI) promotes apoptosis and decreases G0/G1 phase cells in ... This is particularly relevant as senescent cancer cells can contribute to tumor progression and resistance to therapy.

* Tissue Regeneration and Aging: The accumulation of senescent cells is a significant contributor to age-related tissue degeneration.FOXO4-DRIis asenolytic peptidethat induces apoptosis of senescent cells. Product Information. Catalog Num, A22834. Formula, C228H388N86O64. Molecular Weight ... By clearing these cells, FOXO4-DRI may help restore tissue function and alleviate age-related declineSenolytic Peptide Foxo4-DriSelectively Removes Senescent Cells From In Vitro Expanded Human Chondrocytes.. For instance, studies in naturally aged mice have indicated that FOXO4-DRI can improve the testicular microenvironment and alleviate age-related testosterone secretion insufficiency, and promote spermatogenesis.

* Doxorubicin-Induced Senescence: Investigations have examined the senolytic effect of FOXO4-DRI on doxorubicin-induced senescent and non-senescent WI-38 cells, highlighting its potential application in managing chemotherapy-induced side effects or understanding drug resistance mechanisms.

Understanding the "DRI" in FOXO4-DRI

The "DRI" in FOXO4-DRI stands for "D-retro-inverso." This refers to a specific chemical modification of the peptide sequence. By altering the stereochemistry and orientation of the amino acids, the peptide becomes more resistant to degradation by cellular enzymes, increasing its stability and bioavailability within the body. This modification is crucial for the peptide to effectively reach its target and exert its senolytic effect.

Future Directions and Considerations

While the preclinical data on FOXO4-DRI is promising, further research is essential to fully elucidate its therapeutic potential. This includes rigorous clinical trials to assess its safety, efficacy, and optimal dosage in humansFOXO4-DRIis apeptideacting as a specificFOXO4blocker. It has been demonstrated to alleviate age-related testosterone secretion insufficiency.. The development of advanced delivery systems and a deeper understanding of potential off-target effects will also be critical.FOXO4-DRI Acetate； - 楚肽生物科技 Furthermore, exploring the synergistic effects of FOXO4-DRI with other senolytic peptides or therapeutic modalities, such as UBX0101 (another senolytic targeting Bcl-xL), could enhance their overall effectiveness in clearing senescent cells. The scientific community continues to explore novel senolytic peptides and their applications in combating age-related diseases and promoting longevity.Senolytic Peptide Foxo4-DriSelectively Removes Senescent Cells From In Vitro Expanded Human Chondrocytes.